Table 2.
Blood parameters on the day of arterial thrombosis signs and symptoms appearing in patients with/without COVID-19 pneumonia.
| Characteristics, Mean (SD) | Patients Values | Patients with Pneumonia | Patients without Pneumonia | p |
|---|---|---|---|---|
| Neutrophils, ×109/L | 14.22 (6.72) | 15.88 (6.19) | 8.39 (5.67) | 0.025 * |
| Lymphocytes, ×109/L | 0.98 (0.55) | 0.88 (0.51) | 1.35 (0.55) | 0.018 * |
| LDH U/L | 725.6 (532.9) | 841.0 (552.7) | 321.8 (79.9) | 0.038 * |
| CRP, mg/L | 92.4 (78.7) | 111.0 (79.2) | 27.4 (25.4) | 0.016 * |
| D-dimer mg/L | 22.11 (11.08) | 24.78 (9.12) | 12.73 (13.59) | 0.170 |
| Thrombocytes ×109/L | 305.78 (114.67) | 297.07 (107.98) | 336.25 (149.61) | 0.611 |
| Creatine kinase U/L | 1301.28 (1356.16) | 1554.57 (1421.12) | 415.75 (568.07) | 0.031 * |
| NT-proBNP pg/mL | 1849.94 (2104.41) | 2042.71 (2361.44) | 1175.25 (387.48) | 0.556 |
| Troponin ng/L | 91.63 (129.25) | 96.22 (144.88) | 75.55 (57.04) | 0.758 |
| Neutrophils-lymphocyte ratio (NLR) | 22.4 (20.1) | 27.0 (20.5) | 6.1 (2.2) | 0.035 * |
| %PT | 73 (22) | 72 (22) | 78 (22) | 0.555 |
| INR | 1.22 (0.12) | 1.23 (1.13) | 1.19 (0.11) | 0.875 |
*: statistically significant; SD: standard deviation; p: p-value; CRP: C-reactive protein; LDH: lactate-dehydrogenase; NT-proBNP: N-terminal–pro-brain natriuretic peptide; %PT: prothrombin time activity percentage; INR: international normalised ratio.